Narayana Hrudayalaya Ltd.NHCorporate

Healthcare Medical Care Facilities Latest results: Jun 2026 15 quarters of data
₹1,719.40
MCap ₹34,921 Cr · P/E 63.1
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹1,097 Cr
Sales · Jun 2026
+16.3% YoY
₹239 Cr
Operating Profit · Jun 2026
+33.6% YoY
21.8%
OPM % · Jun 2026
+14.7% YoY
₹138 Cr
Net Profit · Jun 2026
+57.8% YoY
₹6.79
EPS · Jun 2026
+57.9% YoY

📝 Narayana Hrudayalaya Ltd. — results explained

Quarter ended June 2026 (Q1 FY27)

Narayana Hrudayalaya Ltd. reported revenue of ₹1,097 crore for the quarter ended June 2026 (Q1 FY27), up 16.3% from ₹943 crore in the same quarter last year, and up 5.1% sequentially over the March 2026 quarter.

Net profit rose 57.8% year-on-year to ₹138 crore, from ₹87 crore. Earnings per share (EPS) came in at ₹6.79.

Operating profit stood at ₹239 crore — an operating margin (OPM) of 21.8%, compared with 19.0% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Narayana Hrudayalaya Ltd. posted revenue of ₹3,975 crore, a growth of 10.7% over FY25, with a net profit of ₹503 crore (up 16.7% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹4,129 crore with a net profit of ₹553 crore.

Valuation snapshot

At the current price of ₹1,719.40, NH has a market capitalisation of ₹34,921 crore and a trailing P/E of about 63.1.

Within the Medical Care Facilities industry, it is the 7th-largest of the 11 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 63.27%, foreign institutional investors (FIIs) 9.01%, domestic institutional investors (DIIs) 10.68%, public shareholders 16.42% of Narayana Hrudayalaya Ltd..

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹34,921 Cr
Current Price ?
₹1,719.4
P/E ?
63.09above ind
Industry P/E ?
56.40
P/B ?
13.45
P/S ?
8.46
P/FCF ?
144.30
Enterprise Value ?
₹36,891 Cr
EV/EBITDA ?
40.99
PEG ?
2.25
Earnings Yield ?
1.9%
Dividend Yield ?
0.26%
Profitability & Returns
Sales (TTM) ?
₹4,129 Cr
OPM ?
21.8%
Profit after tax (TTM) ?
₹553 Cr
EPS (TTM) ?
₹27.25
ROCE ?
20.0%
ROE ?
21.3%
ROA ?
10.2%
Growth
Sales — latest qtr ?
₹1,097 Cr
PAT — latest qtr ?
₹138 Cr
YoY qtr sales growth ?
16.3%
YoY qtr profit growth ?
57.8%
Sales growth (3y) ?
10%
Sales growth (5y) ?
19%
Profit growth (3y) ?
28%
Profit growth (5y) ?
56%
Financial Health
Debt ?
₹1,970 Cr
Debt to Equity ?
0.76
Interest Coverage ?
5.1
Current Ratio ?
N/A
Ownership
Promoter holding ?
63.27%
Change in promoter holding ?
-0.58%
Pledged percentage ?
N/A
Market
Return 3 months ?
-15.3%
Return 6 months ?
-5.8%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 7377847978527718468729348659199431,0199691,0441,097 +16.3% +5.1%
Operating Profit 130118138164138157157183157176179229205227239 +33.6% +5.3%
Other Income 106191411891413910716171612730 +85.0% -76.1%
Interest 121413131314202021263129293934 +9.9% -13.7%
Depreciation 383938394144394243464846475148 +1.2% -5.6%
Profit Before Tax 90127961269518711013410121111717199264188 +60.1% -28.9%
Net Profit 5892791097915886106791608713876202138 +57.8% -31.8%
EPS 2.884.523.865.363.877.784.255.203.907.884.306.793.739.896.79 +57.9% -31.3%
OPM % 17.7% 15.1% 17.3% 19.2% 17.9% 18.5% 18.0% 19.5% 18.1% 19.1% 19.0% 22.5% 21.1% 21.7% 21.8% +14.7% +0.5%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹3,590 Cr ₹3,975 Cr ₹4,129 Cr +10.7%
Operating Profit ₹672 Cr ₹840 Cr ₹900 Cr +25.1%
OPM % 18.71% 21.13% 21.80% +12.9%
NPM % 12.01% 12.65% 13.40% +5.3%
Other Income ₹142 Cr ₹176 Cr ₹190 Cr +24.1%
Depreciation ₹169 Cr ₹192 Cr ₹192 Cr +13.3%
Interest ₹88 Cr ₹127 Cr ₹130 Cr +45.2%
EBIT ₹502 Cr ₹648 Cr ₹708 Cr +29.0%
PBT ₹557 Cr ₹652 Cr ₹722 Cr +17.1%
Tax ₹126 Cr ₹87 Cr ₹107 Cr -30.9%
Net Profit ₹431 Cr ₹503 Cr ₹553 Cr +16.7%
EPS ₹21.23 ₹24.71 ₹27.20 +16.4%
Material Cost ₹828 Cr ₹674 Cr ₹713 Cr -18.5%
Employee Cost ₹688 Cr ₹531 Cr ₹546 Cr -22.8%
Extraordinary Items — ₹-45 Cr ₹-45 Cr —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 204204204204 +0.0%
Reserves 1,2641,6361,9812,393 +20.8%
Borrowings 6441,0111,5951,970 +23.5%
Other Liabilities 664645722856 +18.6%
Total Liabilities 2,7773,4964,5025,424 +20.5%
Fixed Assets 1,3581,4802,3252,459 +5.8%
CWIP 323443209 +386.0%
Investments 6781,0211,1661,087 -6.8%
Other Assets 7099629671,668 +72.5%
Total Assets 2,7773,4964,5025,424 +20.5%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 516542523759 +45.1%
Cash from Investing Activity -621-761-755-965 -27.8%
Cash from Financing Activity 65237391134 -65.7%
Net Cash Flow -4019159-73 -145.9%
Free Cash Flow 27240-181242 +233.7%
CFO/OP 120%101%91%109% +19.8%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 22212530 +20.0%
Inventory Days 17282016 -20.0%
Days Payable 211192168175 +4.2%
Cash Conversion Cycle -172-143-122-129 -5.7%
Working Capital Days -40-39-33-6 +81.8%
ROCE % 23%23%19%20% +5.3%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 63.85%63.85%63.27%63.27%63.27% +0.0%
FIIs 10.46%10.49%11.10%9.98%9.01% -9.7%
DIIs 8.09%7.76%7.91%9.14%10.68% +16.8%
Government 0.00%0.00%0.00%0.00%— —
Public 16.98%17.29%17.09%16.98%16.42% -3.3%
Others 0.62%0.62%0.62%0.62%— —
No. of Shareholders 2,05,6392,26,4802,28,1232,20,5611,98,623 -9.9%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 APOLLOHOSP Apollo Hospitals ₹7,988.50 114,862 59.2 25,229 2,002 14.9% 7.9% 15.8% 33.1% 18.1% 32.9%
2 MAXHEALTH Max Healthcare ₹1,037.70 101,000 69.2 8,712 1,457 26.6% 16.7% 19.1% 34.1% 16.7% 4.9%
3 MANIPALHOS Manipal Health ₹710.85 93,504 — — — — — — — 28.2% -8.3%
4 FORTIS Fortis Healthcare ₹887.80 67,025 64.3 9,128 1,064 22.8% 11.7% 17.3% 31.4% 17.8% 44.1%
5 ASTERDM Aster DM ₹763.50 66,552 198.5 4,876 363 19.0% 7.5% 44.2% 138.8% 21.6% -68.9%
6 MEDANTA Global Health ₹1,445.60 38,846 69.8 4,683 553 20.9% 11.8% 19.4% 15.1% 26.5% -1.1%
7 NH Narayana Hrudayalaya ₹1,869.90 37,978 46.6 9,073 817 19.3% 9.0% 41.4% 1.9% 78.0% 5.4%
8 KIMS Krishna Institute ₹767.50 30,711 148.9 4,214 194 19.8% 4.6% 28.7% -41.5% 35.3% -56.0%
9 RAINBOW Rainbow Children's ₹1,450.00 14,710 51.6 1,820 290 31.6% 15.9% 12.4% 15.2% 33.2% 16.2%
10 GAUDIUMIVF Gaudium IVF ₹116.42 847 36.4 106 23 32.9% 21.8% — — 9.1% -42.2%
11 MOMSBELIEF Rays of Belief ₹223.00 466 — — — — — — — 136.4% 616.1%
❓ Frequently asked questions
What was Narayana Hrudayalaya Ltd.'s revenue in Q1 FY27?
Narayana Hrudayalaya Ltd. reported revenue of ₹1,097 crore for the quarter ended June 2026 (Q1 FY27), up 16.3% from ₹943 crore in the same quarter last year, and up 5.1% sequentially over the March 2026 quarter.
What was Narayana Hrudayalaya Ltd.'s net profit in Q1 FY27?
Net profit rose 57.8% year-on-year to ₹138 crore, from ₹87 crore. Earnings per share (EPS) came in at ₹6.79.
What is NH's market capitalisation and P/E ratio?
At the current price of ₹1,719.40, NH has a market capitalisation of ₹34,921 crore and a trailing P/E of about 63.1.
Who owns Narayana Hrudayalaya Ltd.? (shareholding pattern)
As of Sep 2026, promoters held 63.27%, foreign institutional investors (FIIs) 9.01%, domestic institutional investors (DIIs) 10.68%, public shareholders 16.42% of Narayana Hrudayalaya Ltd..
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI